Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000008

President and CEO acquired 89,520 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2024-01-03 Grant or award +89,520 272,957 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2024-01-03 Grant or award · Stock Option (right to buy) +268,560 268,560 D: show line 2 in the form
Loading xslF345X05/wk-form4_1704495377.xml…